APA (7th ed.) Citation

Limmer, S., Nerschbach, V., Eberle, N., Teske, E., & Betz, D. S. (2022). Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma. BMC.

Chicago Style (17th ed.) Citation

Limmer, Stefanie, Verena Nerschbach, Nina Eberle, Erik Teske, and Daniela Simon Betz. Efficacy and Tolerability of a 12-week Combination Chemotherapy Followed by Lomustine Consolidation Treatment in Canine B- and T-cell Lymphoma. BMC, 2022.

MLA (9th ed.) Citation

Limmer, Stefanie, et al. Efficacy and Tolerability of a 12-week Combination Chemotherapy Followed by Lomustine Consolidation Treatment in Canine B- and T-cell Lymphoma. BMC, 2022.